Sea Crest Wealth Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sea Crest Wealth Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$83.14 - $145.99 $81,061 - $142,340	-975 Reduced 34.82%	1,825 $266,000
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $5,504 - $7,145	-50 Reduced 1.75%	2,800 $332,000
Q4 2021 Feb 11, 2022	BUY	$99.73 - $148.48 $17,452 - $25,984	175 Added 6.54%	2,850 $393,000
Q3 2021 Nov 16, 2021	BUY	$98.85 - $138.91 $29,655 - $41,673	300 Added 12.63%	2,675 $372,000
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $156,227 - $249,422	2,375 New	2,375 $231,000
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $169,785 - $243,137	-2,650 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$65.07 - $98.24 $172,435 - $260,336	2,650 New	2,650 $227,000
Q2 2019 Jul 19, 2019	SELL	$39.79 - $67.01 $86,145 - $145,076	-2,165 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$34.52 - $53.29 $517 - $799	15 Added 0.7%	2,165 $111,000
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $6,558 - $8,600	-200 Reduced 8.51%	2,150 $81,000
Q2 2018 Aug 03, 2018	BUY	$23.62 - $42.29 $8,267 - $14,801	350 Added 17.5%	2,350 $93,000
Q1 2018 Apr 20, 2018	SELL	$22.49 - $34.56 $7,871 - $12,096	-350 Reduced 14.89%	2,000 $52,000
Q4 2017 Feb 02, 2018	BUY	$20.44 - $35.56 $48,034 - $83,566	2,350	2,350 $63,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.